Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

Schieffer, Bernhard, Bünte, Christoph, Witte, Jana, Hoeper, Kirsten, Böger, Rainer H., Schwedhelm, Edzard, Drexler, Helmut·2004·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2004.03.065

Cited by (239)

Items 201–239 of 239

  1. Predictor of event-free survival in patients with myocardial infarction
    Loghman Henareh, Margareta Berglund · 2012 · Acute Cardiac Care
  2. Patients With Hypertension and the Cardiometabolic Syndrome: The Potential Impact of Inflammatory Biomarkers
    Alanna A. Morris, Keith C. Ferdinand · 2009 · Journal of Clinical Hypertension
  3. Inflammation and Innate Immune Response
    2010 · CRC Press eBooks
  4. Metabolic Syndrome: An Emerging Threat
    Rahman, Quazi Audry Arafat, Razzak, Md Abdur, Wahab, Md Abdul · 2020 · Journal of Armed Forces Medical College, Bangladesh
  5. The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats
    Polyana Lima Meireles Dalpiaz, Aline Zandonadi Lamas, Izabela Facco Caliman, A RS Medeiros, G.R. Abreu, Margareth Ribeiro Moysés, Thaysi Andrade, Maria Fernanda Victória Alves, A.K. Carmona, Nazaré Souza Bissoli · 2013 · Brazilian Journal of Medical and Biological Research
  6. Gender-Based Health Disorders in End-Stage Renal Disease Patients in the Hospital Elmarj City of Libya
    Amad M Mohammad, Ari Yuni Astuti · 2017 · Jurnal Kesehatan Masyarakat
  7. Leishmaniasis: effect of enalaprilat on the production of (ON) and cytokines in vitro
    Cristiane Ferreira Lopes de Araújo, Josué Ribeiro da Silva Nunes, Rogério Alexandre Nunes dos Santos, Fabrício Rios-Santos · 2021 · Research Society and Development
  8. Ranolazine, But not Trimetazidine, Influences Markers of Inflammation in Patients with Stable Coronary Artery Disease
    Miran Šebeštjen · 2021 · Biomedical Journal of Scientific & Technical Research
  9. Rationale for and Design of the CREATIVE-AF Trial
    Andreas Goette, Alessandra D’Alessandro, Alicja Bukowska, Siegfried Kropf, Christian Mewis, Christoph Stellbrink, Jürgen Tebbenjohanns, Christian H. Weiß, Uwe Lendeckel · 2008 · Clinical Drug Investigation
  10. Langzeitverlauf kardiovaskulärer Risikomarker bei Patienten mit Hypertonie
    Ulrich Tebbe, Stephan Lüders, F. de Haan, Peter Bramlage, Michael Böhm, Martin Thoenes, W. Dieter Paar, Joachim Schrader · 2007 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  11. APPROACH TO THE SUCCESSFUL SELECTION OF ANTIHYPERTENSIVE AGENTS FOR THE PATIENT WITH ATHEROSCLEROSIS
    Manuel Velasco, Edward Rojas · 2010 · Redalyc (Universidad Autónoma del Estado de México)
  12. The Endothelium, Cardiovascular Disease, and Therapy
    T. Barry Levine, Arlene Bradley Levine · 2012 · Wiley eBooks
  13. Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease
    Carmine Zoccali, Daniela Leonardis, Francesca Mallamaci · 2011 · Wiley eBooks
  14. The diagnosis and treatment of myocardial and arterial dysfunction in Marfan Syndrome.
    Andrew Williams · 2011 · ORCA Online Research @Cardiff (Cardiff University)
  15. Pharmacological Treatment of the Insulin Resistance Syndrome in People Without Diabetes
    Vivian Andrew Fonseca, Christina Bratcher, Tina Kaur Thethi · 2005 · Metabolic Syndrome and Related Disorders
  16. Fármacos antihipertensivos y aterogénesis
    Christian F. Rueda‐Clausen, A.P. Couto, David Sanz‐Rosa, N. de Las Heras, Eva Cediel, María Miana, Victoria Cachofeiro, Vicente Lahera · 2005 · Clínica e Investigación en Arteriosclerosis
  17. Factores que influyen en las concentraciones plasmáticas de proteína C reactiva en los pacientes con diabetes mellitus tipo 2
    José Miguel González-Clemente, María José Barahona, Dı́dac Mauricio, Gabriel Giménez‐Pérez · 2005 · Medicina Clínica
  18. Papel de la angiotensina II en el proceso aterosclerótico
    María Miana, Natalia de las Heras, Beatriz Martín‐Fernández, María Valero‐Muñoz, Ernesto Martínez‐Martínez, Sandra Ballesteros, Raquel Jurado-López, Victoria Cachofeiro, Vicente Lahera · 2011 · Clínica e Investigación en Arteriosclerosis
  19. Association/National Heart, Lung, and Blood Institute Scientific Statement Diagnosis and Management of the Metabolic Syndrome: An American Heart
    Cassidy S. Smith, John A. Spertus, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato · 2006
  20. Telmisartan inhibiert proinflammatorische Zytokine und die Expression von aM/ß2-Integrin auf humanen T-Lymphozyten
    Dominik Legner · 2006 · Publications of the UdS (Saarland University)
  21. Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis
    Barbora Vozarova de Courten, Melissa Barber, Renea V Johnston, Danny Liew, Maximilian de Courten, Sharon Van Doornum, Christopher Michael Reid, Rachelle Buchbinder · 2008 · Cochrane Database of Systematic Reviews
  22. Envolvimento da angiotensina II nos eventos iniciais da sepse avaliado através de parâmetros hemodinâmicos e inflamatórios
    Letícia Kramer Pacheco · 2009 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  23. Einfluss des AT 1 -Rezeptorantagonismus auf die Hypercholesterinämie-induzierte endotheliale Dysfunktion
    Innere Medizin, Michael Böhm · 2005
  24. Immunohistochemistry on Rodent Circulatory System: Its Possible Use in Investigating Hypertension
    Chun‐Yi Ng, Yusof Kamisah, Kamsiah Jaarin · 2015 · Springer eBooks
  25. Dietary Modulation of the Inflammatory Response
    Raffaele De Caterina, Carmine Zoccali · 2008 · Elsevier eBooks
  26. The Renin-Angiotensin System, Capri 2005
    &NA; · 2005 · High Blood Pressure & Cardiovascular Prevention
  27. RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
    S.R. Willoughby, Sharmalar Rajendran, Wai Ping Alicia Chan, Nathan E. K. Procter, Sue Leslie, Elizabeth A. Liberts, Tamila Heresztyn, Yuri Y Chirkov, John David Horowitz · 2012 · Rational Pharmacotherapy in Cardiology
  28. Diabetes Mellitus in California: Complications, Modifiers and Spatial Determinants
    Jayant V. Rajan · 2016 · eScholarship (California Digital Library)
  29. N-Terminal Pro-Brain Natriuretic Peptide and Right Ventricular Diameter Are Related to Aspirin Resistance in Coronary Artery Disease Patients
    Kamila Marika Cygulska, Łukasz Figiel, Dariusz A. Sławek, Małgorzata Wraga, Marek Dąbrowa, Jarosław Damian Kasprzak · 2021 · Medicina
  30. 儒家思想对中国古代文学的深刻影响——以《大学语文》中的古文为例
    李爱华 · 2001 · 语文学刊：高等教育版
  31. Sartans in the Practice of a Cardiologist
    В. А. Лоллини, Лоллини Светлана Владимировна · 2022 · Кардиология в Беларуси
  32. Marfan Syndrome
    Gisela Teixidó‐Turà, Valentina Galuppo, Arturo Evangelista · 2014 · Springer eBooks
  33. Pharmacological Treatment of the Insulin Resistance Syndrome in People Without Diabetes
    Vivian Andrew Fonseca, Christina Bratcher, Tina Kaur Thethi · 2005 · Metabolic Syndrome and Related Disorders
  34. Mechanisms of SGLT2 inhibition in the kidney
    Taha Sen · 2023 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  35. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
    Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernández-Llimós · 2023 · Revista Portuguesa de Cardiologia
  36. Evaluation of the efficacy of hydro-alcoholic extract of Evolvulus alsinoides L. for the treatment of primary hypertension – A randomized controlled trial
    Mantasha Binth Siraj, Asim Ali Khan, Umar Jahangir, Ayshah Hashimi, Yasmeen Ahmad, Nazim Husain · 2023 · Journal of Ethnopharmacology
  37. ACE Inhibitors: Preferred RAAS Inhibitor in High-Risk Patients as Compared to ARBs
    Mukesh Nandave · 2024 · Springer eBooks
  38. Exploratory Analysis of Plasma Angiotensin-Converting Enzyme 2 and Angiotensin Peptides as Candidate Discriminatory Signals in Breast Cancer: A Pilot Case–Control Study
    Biwash Ghimire, Pradeep Giri, Susan S. Tavernier, Sarah E. Hobdey, Ali Aghazadeh‐Habashi · 2026 · Biomedicines
  39. O desequilíbrio proteolítico da matriz extracelular e a dilatação aórtica na síndrome de marfan: correlações genótipo-fenótipo
    Ana Lebreiro · 2011 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)